These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 20826338)
21. Multiple antigen peptide mimetics containing gp41 membrane-proximal external region elicit broad neutralizing antibodies against human immunodeficiency virus type 1 in guinea pigs. Zhang L; Miao L; Gong X; Zhang H; Yang L; Shi Y; Kong W; Jiang C; Shan Y J Pept Sci; 2013 Aug; 19(8):491-8. PubMed ID: 23794478 [TBL] [Abstract][Full Text] [Related]
22. Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice. Zhou M; Kostoula I; Brill B; Panou E; Sakarellos-Daitsiotis M; Dietrich U Vaccine; 2012 Mar; 30(11):1911-6. PubMed ID: 22269872 [TBL] [Abstract][Full Text] [Related]
23. Deletion of fusion peptide or destabilization of fusion core of HIV gp41 enhances antigenicity and immunogenicity of 4E10 epitope. Li J; Chen X; Jiang S; Chen YH Biochem Biophys Res Commun; 2008 Nov; 376(1):60-4. PubMed ID: 18762167 [TBL] [Abstract][Full Text] [Related]
24. Constrained peptide models from phage display libraries highlighting the cognate epitope-specific potential of the anti-HIV-1 mAb 2F5. Palacios-Rodríguez Y; Gazarian T; Huerta L; Gazarian K Immunol Lett; 2011 Apr; 136(1):80-9. PubMed ID: 21237206 [TBL] [Abstract][Full Text] [Related]
25. Computational design of protein antigens that interact with the CDR H3 loop of HIV broadly neutralizing antibody 2F5. Azoitei ML; Ban YA; Kalyuzhny O; Guenaga J; Schroeter A; Porter J; Wyatt R; Schief WR Proteins; 2014 Oct; 82(10):2770-82. PubMed ID: 25043744 [TBL] [Abstract][Full Text] [Related]
26. Computational design of high-affinity epitope scaffolds by backbone grafting of a linear epitope. Azoitei ML; Ban YE; Julien JP; Bryson S; Schroeter A; Kalyuzhniy O; Porter JR; Adachi Y; Baker D; Pai EF; Schief WR J Mol Biol; 2012 Jan; 415(1):175-92. PubMed ID: 22061265 [TBL] [Abstract][Full Text] [Related]
27. Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus. McLellan JS; Correia BE; Chen M; Yang Y; Graham BS; Schief WR; Kwong PD J Mol Biol; 2011 Jun; 409(5):853-66. PubMed ID: 21549714 [TBL] [Abstract][Full Text] [Related]
29. Rationale for a vaccine using cellular-derived epitope presented by HIV isolates. Galéa P; le Contel C; Coutton C; Chermann JC Vaccine; 1999 Mar; 17(13-14):1700-5. PubMed ID: 10194825 [TBL] [Abstract][Full Text] [Related]
30. What does it mean to develop an HIV vaccine by rational design? van Regenmortel MHV Arch Virol; 2021 Jan; 166(1):27-33. PubMed ID: 33251565 [TBL] [Abstract][Full Text] [Related]
31. NEP: web server for epitope prediction based on antibody neutralization of viral strains with diverse sequences. Chuang GY; Liou D; Kwong PD; Georgiev IS Nucleic Acids Res; 2014 Jul; 42(Web Server issue):W64-71. PubMed ID: 24782517 [TBL] [Abstract][Full Text] [Related]
32. Conformational and dynamical basis for cross-reactivity observed between anti HIV-1 protease antibody with protease and an epitope peptide from it. Badaya A; Sasidhar YU Int J Biol Macromol; 2018 Oct; 118(Pt B):1696-1707. PubMed ID: 29990556 [TBL] [Abstract][Full Text] [Related]
33. A strategy for selectively shielding portions of a peptide/protein from immune response while maintaining immunogenicity of contiguous epitopes. Bianchi E; Finotto M; Ingallinella P; Citron M; Hrin R; Lu M; Geleziunas R; Miller MD; Liang X; Pessi A Adv Exp Med Biol; 2009; 611():359-60. PubMed ID: 19400225 [No Abstract] [Full Text] [Related]
37. Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens. Liljeroos L; Malito E; Ferlenghi I; Bottomley MJ J Immunol Res; 2015; 2015():156241. PubMed ID: 26526043 [TBL] [Abstract][Full Text] [Related]
38. Computational tools for epitope vaccine design and evaluation. He L; Zhu J Curr Opin Virol; 2015 Apr; 11():103-12. PubMed ID: 25837467 [TBL] [Abstract][Full Text] [Related]
39. Structure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological Theory. Van Regenmortel MH Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27657055 [TBL] [Abstract][Full Text] [Related]